Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02421705

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

Visceral Sensitivity in IBD and IBS: Role of Inflammation, Immune Activity and Genetic Factors

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
99,999,999 (estimated)
Sponsor
KU Leuven · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Aim: More insight in pathogenesis of IBS and IBD. Samples are collected in context of an European research project.

Detailed description

Methods: Sample collection in healthy subjects, IBD and IBS patients: * biopsy of rectum and colon descendens * blood sample collection * collection of sample of nasal mucosa * feces collection * questionnaires * rectal barostat sensitivity measurement * transit measurement of colon * MR scan of brain

Conditions

Interventions

TypeNameDescription
OTHERSample collectionCollection of blood, feces samples, sample of nasal mucosa and biopsies (rectum and colon descendens), questionnaires and performance of rectal sensitivity measurement (barostat), MR scan of brain and transit measurement of colon

Timeline

Start date
2010-02-01
Primary completion
2099-01-01
Completion
2099-01-01
First posted
2015-04-21
Last updated
2023-02-08

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02421705. Inclusion in this directory is not an endorsement.

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome) (NCT02421705) · Clinical Trials Directory